Clinical Trial Update: Naltrexone and Hypoglycemia in Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on naltrexone for hypoglycemia in Type 1 diabetes, completed with results posted in 2014 (Phases 1 and 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia Unawareness
• Type 1 Diabetes Mellitus

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: University of Minnesota | Conditions: Type 1 Diabetes, Hypoglycemia Unawareness | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-09-12